MedTech News
![](https://startllc.com/wp-content/uploads/2024/07/Device-photo-2-1-300x200.jpg)
Detachable cardiac pacing lead may improve safety for cardiac patients
The minimally invasive, 3d-printable device offers safer application and removal, along with improved bioelectronic performance.
![](https://startllc.com/wp-content/uploads/2024/07/HERR-Nature-Medicine-Image-01_0-300x200.jpg)
A prosthesis driven by the nervous system helps people with amputation walk naturally
A new surgical procedure gives people more neural feedback from their residual limb. With it, seven patients walked more naturally and navigated obstacles.
![](https://startllc.com/wp-content/uploads/2024/07/MTI-Website-76-300x174.jpg)
Rady Children’s announces launch of new no-cost 3D model viewing technology
Developed using Unity, the software allows viewing of advanced 3D reconstructions directly on a surgeon’s computer.
![](https://startllc.com/wp-content/uploads/2024/07/IceCure-Medical-Updated-Logo-300x195-1.jpg)
FDA clears IceCure Medical’s next-gen single-probe cryoablation system
IceCure Medical (Nasdaq:ICCM) announced today that the FDA granted clearance for its next-generation single-probe cryoablation system
![](https://startllc.com/wp-content/uploads/2024/07/CeQur-Simplicity-300x195-1.webp)
CeQur wins FDA nod for mealtime insulin delivery device
Each patch now replaces up to 12 mealtime injections, equaling more than 1,000 fewer injections annually, according to a news release.
![](https://startllc.com/wp-content/uploads/2024/07/researchers-develop-an-1-300x199.jpg)
Researchers develop an alternative to pacemakers in the form of a hydrogel
A heart attack is a life-threatening condition, with patients remaining at risk of premature death long after the actual attack—50% to 60% of patients die subsequently as a result of sudden cardiac death, triggered by cardiac arrhythmia.
![](https://startllc.com/wp-content/uploads/2024/07/Cepheid-Xpress-System-Web-Left-300x237.png)
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
SILVER SPRING, Md., June 27, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to appropriately certified point-of-care settings for individuals at risk for hepatitis C.
![](https://startllc.com/wp-content/uploads/2024/07/MicroVention-LVIS-EVO-300x195-1.jpg)
MicroVention launches new stent in the U.S.
Terumo subsidiary MicroVention announced that it began the U.S. launch for its LVIS EVO intraluminal support device.